Simple Observational Critical Care Studies
Launched by UNIVERSITY MEDICAL CENTER GRONINGEN · Jun 10, 2018
Trial Information
Current as of July 21, 2025
Unknown status
Keywords
ClinConnect Summary
Registry procedures:
Eligible patients will be included within 3 hours after their arrival on the Intensive Care Unit. After inclusion all study parameters will be obtained through physical and physiological examination. This will be repeated at 12 circa hours, and circa 24 hours thereafter.
Monitoring:
Monitoring will be performed by independent researchers of the department of critical care of the University Medical Center Groningen (UMCG). Audits are planned to take place once a year.
Recruitment:
Inclusion of patients and measurements of variables will be performed by the study coo...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Emergency admission
- • Expected stay \> 24 hours
- Exclusion Criteria:
- • Age \< 18 years
- • Planned admission either after surgery or for other reasons
- • Suicide attempts due to acute psychiatric 'derailment', mental retardation or a language barrier
About University Medical Center Groningen
University Medical Center Groningen (UMCG) is a leading academic medical center in the Netherlands, renowned for its commitment to innovative research, high-quality patient care, and extensive education in the medical field. As a prominent sponsor of clinical trials, UMCG leverages its multidisciplinary expertise and state-of-the-art facilities to advance medical knowledge and improve therapeutic outcomes. The center fosters collaboration among researchers, healthcare professionals, and industry partners, aiming to translate scientific discoveries into effective treatments that enhance patient health and well-being. With a focus on ethical standards and regulatory compliance, UMCG is dedicated to conducting clinical trials that contribute to the advancement of medicine and the betterment of society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Groningen, , Netherlands
Groningen, , Netherlands
Patients applied
Trial Officials
Iwan C.C. van der Horst, M.D., Ph.D.
Principal Investigator
University Medical Center Groningen
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials